The effectiveness of blinatumomab in clearing measurable residual disease in pediatric B-cell acute lymphoblastic leukemia patients detected by next-generation sequencing.
Min'er GuYahong XiaJingying ZhangYongmin TangWeiqun XuHua SongXiaojun XuPublished in: Cancer medicine (2023)
Our study was the first to demonstrate that blinatumomab could further eradicate MRD after patients achieve MFC-MRD undetectable in B-ALL patients.